Archive

Category Archives for "News"

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $11,250,000 Registered Direct Offering

vuzix view the future logo

Press Release – New York, New York – May 13, 2020 – Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI) in a registered direct offering of 5,000,000 shares of its common stock at a price of $2.25 per share for gross proceeds of approximately $11,250,000. 

The Sichenzia Ross Ference LLP team was led by partner Gregory Sichenzia, counsel Jeffrey Cahlon, and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement 

lexaria bioscience logo

Press Release – New York, New York – May 7, 2020 –  Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common stock and warrants for gross proceeds of approximately $2 million. 

The Special Equities Group, a division of Bradley Woods & Co. Ltd., acted as the exclusive placement agent for the offering.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Jacob Tabman.

Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – April 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 12,600,000 shares of Avinger, Inc. (NASDAQ: AVGR) common stock at a price of $0.25 per share, for total gross proceeds of approximately $3.15 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

60 Days And Counting: “Regulation Best Interest” Is Nearly Here. Are Independent Broker-Dealers Ready? What They Need to Know and Do

On June 5, 2019, the United States Securities and Exchange Commission (“Commission”) adopted Rule 15l-1 (“Regulation Best Interest”) under the Securities Exchange Act of 1934 (“Exchange Act”), which has a compliance date of June 30, 2020.[1]  Regulation Best Interest became effective September 10, 2019.  Notwithstanding the host of issues arising from the global pandemic, an economic recession and significant market volatility across essentially every sector, the Commission has made clear that the deadline for compliance with Regulation Best Interest and the related Form CRS requirements will not be delayed or extended.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $8.4 Million Underwritten Public Offering of Safe-T Group Ltd.

safe-t logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented A.G.P./Alliance Global Partners as sole book-running manager in an underwritten public offering of the securities of Safe-T Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments. The securities offered by the company consisted of (i) 858,600 units, each comprised of one American Depositary Share (“ADS”), representing 40 ordinary shares, and one warrant to purchase one ADS (“Warrant”), and (ii) 6,777,500 pre-funded units, each comprised of one pre-funded warrant to purchase one ADS and one Warrant.  The offering price was $1.10 per unit and $1.099 per pre-funded unit. 

continue reading >>

Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering

beyond air logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in an At-The-Market Offering (“ATM”) under which the Company may offer and sell from time to time shares of its common stock having an aggregate offering price of up to $50,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.44 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 722,502 American Depositary Shares (ADSs), each representing 600 of the Company’s ordinary shares, at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $1.8 Million Registered Direct Offering

genetic technologies logo

Press Release – New York, NY – April 3, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,028,574 American Depositary Shares (ADSs), each representing six hundred of the Company’s ordinary shares, at a purchase price of $1.75 per ADS.

continue reading >>

SEC Extends Filing Deadlines for Public Companies and Registered Investment Advisers Affected by COVID-19

On March 25, 2020, the Securities and Exchange Commission (the “SEC”) issued new orders extending the filing periods covered by its previously enacted conditional reporting relief for certain public company filing obligations under the federal securities laws, and also extended regulatory relief previously provided to funds and investment advisers whose operations may be affected by COVID-19.

continue reading >>

Business Interruption Insurance

Dear Clients and Friends,

With widespread government ordered shutdowns resulting from the COVID-19 pandemic, companies are understandably concerned with the interruption to their business operations as well as the financial and economic losses that are beginning to mount. In light of this, it is important that companies take the time to look at their existing insurance policies to examine what options are available to mitigate the impact of the COVID-19 pandemic. The viability of a claim for losses under your existing Property, Event and/or Comprehensive General Liability policies caused by a pandemic or “communicable or infectious diseases” will be largely subject to the specific provisions of your company’s insurance policies.

Sichenzia Ross Ference LLP recommends that all its clients carefully review their insurance policies, including without limitation their Property, Event and Commercial General Liability policies, to determine the scope of coverage for business interruption with particular focus on whether any of those policies include or exclude coverage for losses caused by a communicable or infectious disease such as COVID-19.

We, at Sichenzia Ross Ference LLP, continue to think about our clients and friends during these trying times, and, if there are any ways we might be able to help, ask that you contact us.

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $7.7 Million Overnight Bought Offering of Cel-Sci Common Stock

cel sci

Press Release – New York, NY – March 26, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book-running manager in an offering of 630,500 shares of the common stock of Cel-Sci Corporation (NYSE American: CVM), a biotechnology company. The stock was offered at $12.22 per share for gross proceeds of approximately $7.7 million, less underwriting discounts and other offering expenses.  

continue reading >>

Coronavirus (Covid 19) Update

At Sichenzia Ross Ference LLP, people are our priority. As the world struggles to manage through the impact of the coronavirus (COVID-19), we want to assure you that we are committed to supporting our colleagues, clients, friends and communities as effectively as we have through every other crisis over the decades.

  • Our firm is fully operational: We have adapted and activated our business continuity plans to ensure that our lawyers and team members are able to safely serve our clients’ needs and continue operations on an uninterrupted basis, whether working from our offices or remotely.
  • We encourage you to contact us with any concerns that you may have or topics that you would like to discuss; we are here to support you through these challenging times. Please continue to contact us at the same phone numbers and email addresses that you are accustomed to using.
  • As disruptive as these days are for our clients and colleagues, we know that this virus and efforts to stop its spread will have an even greater impact on the most vulnerable members of our society. Our thoughts go out to all those whose health has been or will be affected by this virus, and our gratitude goes to all the first responders and health care workers courageously working every day to help those who are ill.

We are all in this together, and we will get through it together.

Our thoughts are with you and your loved ones to stay safe and be well.

Founding Partner Gregory Sichenzia Featured in Law360 Article on Coronavirus-fueled Market Volatility

Press Release – New York, NY – March 10, 2020 – Sichenzia Ross Ference LLP today shared that founding name partner Gregory Sichenzia was quoted in Law360 by reporter Tom Zanki in his story, “Market Turbulence Throws IPO Pipeline Into Question.” The story discussed market volatility and IPO plans amid the coronavirus outbreak, including commentary from Sichenzia:

No IPOs are scheduled yet for next week, according to New York Stock Exchange and Nasdaq calendars. Sichenzia Ross Ference LLP partner Greg Sichenzia expects that companies that have not launched roadshows yet will wait for stability before moving forward.

“If you can keep your powder dry, you will,” said Sichenzia, who counsels public and private companies.

Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Pareteum Corporation (NASDAQ: TEUM), a cloud communications platform company, as it entered into a subscription agreement with certain investors for shares of the company’s 8% Series C Redeemable Preferred Stock at a purchase price of $100,000 per share for gross proceeds of $3,750,000.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associate Grant Levine.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $2.9 Million Public Offering of Digital Ally, Inc. Common Stock 

digital ally logo

Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,521,740 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company. The stock was offered at $1.15 per share for gross proceeds of approximately $2.9 million, less underwriting discounts and other offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Alliance Global Partners as Placement Agent in $10M Registered Direct Offering of Aptorum Group Limited

Aptorum logo

Press Release – New York, NY – February 28, 2020 – Sichenzia Ross Ference LLP announced today that it represented Alliance Global Partners as lead placement agent in a registered direct offering of 1,351,350 Class A ordinary shares of Aptorum Group Limited (Nasdaq: “APM”), a biopharmaceutical company. The offering price was $7.40 per share for gross proceeds of $10 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $4.6 Million Public Offering of Common Stock 

document security systems logo

Press Release – New York, NY – February 25, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and diversion protection technologies, in the underwritten public offering of 22,222,223 common shares, plus 3,333,333 shares from the exercise of the underwriter’s purchase option to cover overallotments, at a price of $0.18 per share for gross proceeds of $4.6 million. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.6 Million Offering of Medalist Series A Stock

medalist diversified reit logo

Press Release – New York, NY – February 19, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 200,000 shares of 8% Series A Cumulative Redeemable Preferred Stock of Medalist Diversified REIT, Inc. (Nasdaq:MDRR), a real estate investment trust specializing in the acquisition, ownership and management of value-add commercial real estate.  The shares were sold at an offering price of $23.00 per share for gross proceeds of $4.6 million and commenced trading on the Nasdaq Capital Market under the symbol “MDRRP.”

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $8.1 Million Offering and NASDAQ Listing of Duos Technologies Common Stock

duostech logo

Press Release – New York, NY – February 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager and The Benchmark Company as co-manager in an $8.1 million offering of common stock at $6.00 per share of Duos Technologies Group, Inc. (NASDAQ: DUOT). Simultaneously with the offering, the common stock was approved for listing on the Nasdaq Capital Market and began trading on February 13, 2020 under the symbol DUOT. 

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Follow-On Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – February 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 6,428,572 shares of the common stock of Avinger, Inc.  (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease, at an offering price of $0.70 per share for gross proceeds of $4.5 million. The shares are being offered and sold pursuant to Avinger’s effective registration statement on Form S-1 (Registration No. 333-235902).

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P. in $2.2 Million Common Stock Offering

co crystal pharma inc

Press Release – New York, NY – January 31, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a $2.2 million offering of common stock at $0.63 per share of Cocrystal Pharma, Inc.  (NASDAQ: COCP), a clinical stage biotechnology company developing antiviral therapeutics.  The shares were offered and sold pursuant to Cocrystal’s effective registration statement on Form S-3 (Registration No. 333-220632).

continue reading >>

Sichenzia Ross Ference LLP Represents HiVentures Zrt., a Hungarian Venture Capital Company, in Private Placement of Series A Preferred Stock of ActiveGraf

activegraf logo

Press Release – New York, NY – January 16, 2020 – Sichenzia Ross Ference LLP announced today that it represented MFB Növekedési Tökealap, a Hungarian investment firm, and its manager, Hiventures Zrt., a state-owned venture capital company committed to the promotion of Hungarian start-ups and businesses, in connection with their agreement to purchase approximately $900,000 of Series A preferred stock of ActiveGraf Inc., a private North Carolina-based company creating interactive data analytics.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

cellect logo

Press Release – New York, NY – January 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 1,000,000 American Depositary Shares (“ADSs”) of Cellect Biotechnology Ltd (Nasdaq: “APOP”), a developer of innovative technology enabling the functional selection of stem cells. Each of the ADSs represents 100 of APOP’s ordinary shares. The offering price was $3.00 per ADS for gross proceeds of approximately $3,000,000, less fees and other estimated offering expenses.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.5 Million Follow-On Offering of CEL-SCI Corporation Common Stock

cel sci

Press Release – New York, NY – December 30, 2019 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 606,395 shares of the common stock of CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, at an offering price of $9.07 per share, for gross proceeds of $5.5 million. Pursuant to the terms of the underwriting agreement, Aegis has been granted a 45-day option to purchase up to an additional 90,959 shares of CEL-SCI common stock to cover over-allotments.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio, Avital Perlman and Marcelle Balcombe and associates Grant Levine and Jacob Tabman.

Sichenzia Ross Ference LLP Represents Biotricity Inc. in a $6 Million Private Placement of its Series A Convertible Preferred Stock

biotricity logo

Press Release – New York, New York – December 19, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, in connection with the sale of $6M of its Series A convertible preferred stock.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia and David Manno.

Sichenzia Ross Ference LLP Represents Beyond Air, Inc. in a $11.5 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement

beyond air logo

Press Release – New York, NY – December 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a clinical stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for treatment of severe respiratory conditions, in the successful completion of an underwritten public offering and concurrent private placement of approximately $11.5 million of Beyond Air common stock at a price of $3.66 per share. The public offering was conducted from an effective shelf registration statement filed with the Securities and Exchange Commission.  The private placement shares will not be registered.

continue reading >>

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock

relmada

Press Release – New York, NY – December 6, 2019 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical stage company developing depression and central nervous system disease therapies, in the successful completion of an underwritten public offering of three million shares of Relmada common stock at a price of $30.00 per share.

The underwriters exercised their over-allotment option for an additional 450,000 shares, bringing gross proceeds to $115 million before the deduction of underwriting discounts, commissions, and other estimated offering expenses. Jefferies, SVB Leerink, and Guggenheim Securities are joint book running managers for the offering.

Relmada intends to use the net proceeds to fund research and development for clinical stage programs related to its lead product candidate, REL-1017 (d-methadone), an oral agent for depression which recently produced favorable results in clinical trials.

Sichenzia Ross Ference LLP also represented Relmada in the listing of its Common Stock on the Nasdaq Capital Market, which commenced trading on October 10, 2019. The firm joined Relmada and its executive leadership at its Nasdaq Bell Ringing Ceremony on October 17.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Barrett DiPaolo, Thomas Rose and Associate Grant Levine.

Sichenzia Ross Ference Represents H-Cyte, Inc. in $6.0 Million Private Placement

H-Cyte

Press Release – New York, NY – December 2, 2019 –  Sichenzia Ross Ference LLP acted as H-Cyte’s counsel in a $6.0 million private placement with FWHC, LLC at a price in excess of the market price. H-Cyte is the owner and operator of innovative medical technology products and services including LungCYTE and The Lung Health Institute. H-Cyte intends to utilize the funds to advance its development of industry-leading medical treatments for chronic lung diseases such as COPD. The SRF team was led by partner, Arthur Marcus.

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $3.5 Million Public Offering for Safe-T Group Ltd.

safe-t

Press Release – New York, NY – November 5, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and warrants of Safe-T Group Ltd., a provider of Secure Access solutions for on-premise and hybrid cloud environments (NASDAQ, TASE: SFET).

continue reading >>

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in a $1.8 Million Private Placement

document security systems logo

New York, NY – November 5, 2019 – Sichenzia Ross Ference LLP, announced today that it represented Document Security Systems, Inc. (NYSE American: DSS), a leader in anti-counterfeit, authentication and consumer engagement technology, in a private placement of 6,000,000 shares of the company’s common stock at a purchase price of $0.3037 per share. DSS received gross proceeds of $1,822,200 from the offering, which was funded entirely by the company’s Chairman of the Board of Directors, Mr. Heng Fai Ambrose Chan. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

co crystal pharma inc

Press Release – New York, NY – November 4, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Public Offering of Avinger, Inc. Common Stock

avinger logo

Press Release – New York, NY – August 26, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,813,559 shares of Avinger, Inc. (NASDAQ: AVGR) common stock, at a price of $1.18 per share for gross proceeds of approximately $4.5 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $2.3 Million Public Offering of Common Stock of Sigma Labs, Inc.

sigma labs logo

Press Release – New York, NY – August 2, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 2.875 million shares Common Stock of Sigma Labs, Inc. (NASDAQ: SGLB) at a price of $.80 per share for gross proceeds of $2.3 million.  Sigma Labs is a provider of quality assurance software under the PrintRite3D brand.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $1.35 Million Underwritten Public Offering of ADSs of Immuron Limited

immuron logo

Press Release – New York, NY – July 23, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, as sole book runner in a $1.35 million Public Offering of the ADSs of Immuron Limited (NASDAQ “IMRN” ASX.”IMC”). The offering consisted of 339,130 ADS’s at a price of $4.00 per ADS for gross proceeds to the Company of $1.35 million. Immuron is an Australian biopharmaceutical company focused on oral immunoglobulin therapeutics. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Tara Guarneri-Ferrara.

continue reading >>

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

realwear inc logo

Press Release — July 9, 2019 — New York, NY — Sichenzia Ross Ference LLP represented RealWear, Inc., an innovative technology company whose flagship product, the HMT-1®, is the first ruggedized head-mounted, wearable, Android-class tablet computer that frees a worker’s hands for dangerous jobs, in financing transactions raising an aggregate of $80 million. The Series B financing round was led by Teradyne, Inc. (TER), a global leader in industrial automation, and included participation from other industry leaders including Qualcomm Ventures and Bose Ventures. JPMorgan Chase & Co. acted as the exclusive placement agent to RealWear, Inc. in connection with the Series B financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $20 Million Registered Direct Offering

Vuzix Corporation

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of approximately 5.48 million registered shares of common stock at a price of $3.65 per share and approximately 5.48 million common stock purchase warrants with an exercise price of $4.10 per share  for gross proceeds to Vuzix of approximately $20 million. The Special Equities Group, a division of Bradley Woods & Co. Ltd. acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Tara Guarneri-Ferrara, and Counsel Jeff Cahlon.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented its client, Document Security Systems, Inc. (NYSE American: DSS), in a $5.6 million public offering of its common stock.  The offering consisted of 11.2 million shares of common stock at a price of $0.50 per share. Aegis Capital Corp. served as sole book running manager in connection with the offering. DSS is a leader in the anti-counterfeit, authentication and diversion protection technology space. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia, Darrin Ocasio, Tara Guarneri-Ferrara and Jeffrey D’Angelo.

Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million

medicine man technologies

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man or the “Company”) in a securities purchase agreement with Dye Capital & Co. for the sale of up to $14 million of shares and common stock purchase warrants of the Company. The shares were sold at a price of $2.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $3.0 Million Registered Direct Offering of Common Stock and Warrants of General Cannabis Corp.

Press Release­­ – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that it has represented a FINRA member firm as financial advisor in the registered direct offering of 3.0 million shares of common stock and 3.0 million warrants of General Cannabis Corp. (OTCQX: CANN) at a price of $1.00 per share for gross proceeds of approximately $3.0 million.

continue reading >>

Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP (SRF) announced today that it has represented Aegis Capital Corp. as sole book-running manager in the underwritten public offering of 1.66 million shares Common Stock of Medalist Diversified REIT, Inc.(NASDAQ: MDRR) at a price of $4.80 per share for gross proceeds of $8.0 million.

continue reading >>

Sichenzia Ross Ference LLP Announces $1.3 million Private Placement of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as placement agent in a private offering of 270,833 shares of Common Stock of Medalist Diversified REIT, Inc. (NASDAQ: MDRR) at a purchase price of $4.80 per share for gross proceeds of approximately $1.3 million.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $2.0 Million Underwritten Public Offering of ADSs of Immuron Limited.

immuron logo

Press Release – New York, NY – May 29, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, Inc. as sole book runner in a $2.0 million Public Offering of American Depositary Shares (ADSs) of Immuron Limited (ASX: “IMC”; NASDAQ “IMRN”).

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares

genetic technologies logo

Press Release – New York, NY – May 23, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company, in a registered direct offering of American Depositary Shares (“ADSs”) and warrants to purchase ADSs.  The Company received gross proceeds of approximately $1,200,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement

quest solution

Press Release – New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Quest Solution, Inc.  (OTCQB: QUES) in the private placement of 16,666,667 unregistered shares of its common stock, at a purchase price of $.30 per share, for gross proceeds of approximately $5,000,000. Investors also received warrants to purchase 16,666,667 shares of common stock at an exercise price of $.35 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $25 Million Credit Facility with East West Bank

new age beverage corp. logo

Press Release – New York, NY – April 2, 2019 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with East West Bank which provides for up to $25 million aggregate principal amount revolving credit facility, which includes a $15 million term loan and a feature to provide an additional $10 million should the company choose to utilize it and a $10 million revolving line of credit.

continue reading >>

Sichenzia Ross Ference LLP Represents LiveWell Canada Inc. in $15 Million Private Placements to Scale its CBD Operations

live well

Press Release – New York, NY – March 28, 2019 – Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that it represented LiveWell Canada Inc. (“LiveWell”), a Canadian CBD company listed on the Canadian Stock Exchange entering the U.S. markets, in a private placement offering of senior secured convertible notes with institutional investors for total aggregate gross proceeds of $15 million, which includes LiveWell’s previously closed $3 million bridge financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $5.4 Million Public Offering of Common Stock of Opgen, Inc.

opgen logo

Press Release – New York, NY – March 28, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 9 million shares Common Stock of Opgen, Inc. (NASDAQ: OPGN) at a price of $.60 per share for gross proceeds of $5.4 million.  Opgen is a precision medicine company harnessing the power of molecular diagnostics to combat infectious disease. The Sichenzia Ross Ference LLP team was led by partners Tom Rose, Gregory Sichenzia and Jay Yamamoto.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Represents Pareteum Corporation in $50 Million Credit Facility with Post Road Group

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 20, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a global cloud software communications platform company, as it closed a $50,000,000 committed senior secured credit facility with Post Road Group. Under the terms of the credit facility, Post Road provided Pareteum an initial loan of $25,000,000 on February 26, 2019, with additional loans in increments of $5,000,000 to be made as requested by Pareteum before the 18-month anniversary of the initial funding date.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associates Grant Levine and Huan Lou.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Represents Pareteum Corporation in Tender Offer for Shares of iPass, Inc. and Completes Acquisition

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – February 14, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it accepted for exchange shares  of iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $6.5 Million Public Offering for Cellect Biotechnology Ltd.

cellect logo

Press Release – New York, NY – February 12, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and Warrants of Cellect Biotechnology Ltd., an Israeli biotech company (NASDAQ: APOP). National Securities Corporation and Dawson James Securities, Inc. acted as co-managers for the offering.

continue reading >>

Sichenzia Ross Ference LLP Represents INmune Bio Inc. in an $8 Million Initial Public Offering and Listing on the Nasdaq Capital Market

inmunebio logo

Press Release – New York, NY – February 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented INmune Bio Inc. (INMB), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, in an initial public offering at a price of $8.00 per share resulting in gross proceeds of approximately $8,000,000 and listing on the Nasdaq Capital Market under the ticker symbol INMB.

continue reading >>

Sichenzia Ross Ference LLP Represents Boulder Botanicals & Biosciences Laboratories, Inc. in a $5.0 Million Private Placement

boulder botanicals

Press Release – New York, NY – January 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented Boulder Botanicals & Biosciences Laboratories, Inc.  (BBBL), a holding company which owns and operates several companies operating within the CBD production, extraction and distribution industries in a private placement of shares of common stock at a price of $1.00 per share resulting in gross proceeds of approximately $5,000,000.

continue reading >>

Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to China SXT Pharmaceuticals, Inc.’s $10.2 Million U.S. Initial Public Offering

china sxt pharmaceuticals

Press Release – New York, NY – January 4, 2019 – Sichenzia Ross Ference LLP congratulates China SXT Pharmaceuticals, Inc. (the “Company”) (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (“TCMPs”), on the final closing of its initial public offering on January 3, 2019. Together with the first closing on December 31, 2018, the Company raised approximately $10.2 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,546,275 ordinary shares at a public offering price of $4.00 per share. The shares are scheduled to commence trading on the NASDAQ Capital Market today at around 2:05 p.m. ET under the ticker symbol “SXTC.”

continue reading >>

Sichenzia Ross Ference LLP Represents New Age Beverages Corporation in the $85 Million Acquisition of Morinda Holdings, Inc.

new age beverage corp. logo

NEW YORK, Jan. 03, 2019 — Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that its mergers and acquisitions team represented New Age Beverages Corporation (NASDAQ:NBEV) in its acquisition of Morinda Holdings, Inc., a Utah-based healthy beverages and lifestyle company with operations in more than 60 countries worldwide.

The consideration for the merger was $85 million, comprised of $75 million in cash and $10 million paid in 2,016,480 shares of New Age common stock based on the 40-day volume-weighted average price calculated through December 20, 2018. The transaction was subject to the pre-merger notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and closed on December 21, 2018.

The full Sichenzia Ross release can be found here.

continue reading >>

Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $10 Million Public Offering for Creative Realities, Inc.

creative realities logo

Press Release – New York, NY – November 19, 2018 –  Sichenzia Ross Ference LLP announced today that it has represented A.G.P/ Alliance Global Partners  (through Euro Pacific Capital) as sole book running manager in the underwritten public offering of shares of Common Stock and Warrants of Creative Realities, Inc. (NASDAQ: CREX).

continue reading >>

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $52 Million Underwritten Public Offering

new age beverage corp. logo

Press Release – New York, NY – November 14, 2018 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in an underwritten public offering of 14,835,000 shares of its common stock, which includes a full simultaneous exercise of the underwriters 15% over allotment option, at a public offering price of $3.50 per share for gross proceeds to NBEV of $51,922,500. Roth Capital Partners and A.G.P/ Alliance Global Partners acted as joint book-running managers for the offering. Please click here to read the full Sichenzia Ross release.

continue reading >>

Sichenzia Ross Ference Represents Pareteum Corporation in Definitive Agreement to Acquire iPass, Inc.

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – November 13, 2018 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it entered into a definitive agreement under which it will acquire iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity, in an all-stock transaction. Pareteum anticipates achieving more than $15 million in annual cost synergies; more than $12 million of such synergies are expected to be realized in the first year.

continue reading >>

Sichenzia Ross Ference LLP Represents Novume Solutions, Inc. in $3.3 Million Underwritten Public Offering of Common Stock

novume logo

Press Release – New York, NY – November 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented Novume Solutions, Inc. (NASDAQ “NVMM”) in a public offering of 4.125 million shares of its common stock at a price of $.80 per share for gross proceeds to the Company of $3.3 million.
continue reading >>

Sichenzia Ross Ference LLP Represents Wize Pharma, Inc. in a $4.45 Million Private Placement

wize pharma

New York, NY – October 24, 2018 – Sichenzia Ross Ference LLP, announced today that it represented Wize Pharma, Inc. (OTCQB: “WIZP”), a clinical stage Israel based U.S. public company focused on the treatment of ophthalmic disorders company, in a private placement with institutional and accredited investors  of 3,100,000 shares of common stock at $1.00 per share and 1,350 shares of newly created Series A preferred stock which is convertible at $1.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents Rodman & Renshaw a Unit of H.C Wainwright in a $15 Million Upsized Public Offering of Medical Transcript Billing, Corp.

mtbc.com logo

Press Release – New York, NY – October 15,  2018 – Sichenzia Ross Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference Represents Pareteum Corporation in $40 Million Offering of Common Stock and Warrants

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – September 27, 2019 – Nationally-recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: “TEUM”), global cloud software communications platform company, in an underwritten public offering of 18,852,273 Common Stock Units, each consisting of one share of TEUM’s common stock, one Series A Purchase Warrant to purchase one share of TEUM’s common stock, and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock, and 3,875,000 Pre-Funded Units, consisting of one pre-funded warrant to purchase one share of TEUM’s common stock together with one Series A Purchase Warrant to purchase one share of TEUM’s common stock and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity, a division of Fordham Financial Management as Sole Book-Running Manager on $10 Million Public Offering of Securities of  FlexShopper, Inc.

flexshopper

Press Release – New York, NY – October 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc. as sole book-running manager in an underwritten public offering of $10 Million of Units of FlexShopper, Inc. (Nasdaq FPAY).

continue reading >>

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $12 Million Credit Facility

new age beverage corp. logo

Press Release – New York, NY – August 24, 2018 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with Siena Lending Group LLC which provides for a $12 million aggregate principal amount revolving credit facility, which is subject to availability based on eligible accounts receivables and eligible inventory of the Company.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corporation in a $4.75 Debt Transaction

new age beverage corp. logo

Press Release – New York, NY – June 20, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented New Age Beverages Corporation (“NASDAQ. NBEV”), a Colorado based organic and natural healthy beverage company in a $4.75 million senior secured convertible promissory note transaction. A portion of the proceeds were used to repay the Company’s line of credit with US Bank. The Company also converted debt held by Sunkist Growers, Inc. an agricultural marketing cooperative, into shares of its common stock.

The Sichenzia Ross Ference Kesner LLP team was led by Partners, Gregory Sichenzia and Marcelle Balcombe and Of Counsel, Kimberly Boler.

Sichenzia Ross Ference Kesner LLP Represents ThinkEquity, a Division of Fordham Financial Management as Sole Book-Running Manager on $18 Million Public Offering of Securities of Trovagene, Inc.

trovagene logo

Press Release – New York, NY – June 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager on its first underwritten public offering since launching its new ThinkEquity division.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.1 Million Registered Direct Offering

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

New York, NY – May 14, 2018 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it represented Pareteum Corporation (NYSE: TEUM), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering of 2,440,000 shares of common stock. The purchase price per share was $2.50. Pareteum received gross proceeds of $6.1 million.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Acolyte Group in the Sale of its LED Lighting Business to CapStreet Private Equity Group

acolyte group

May 2, 2018 — New York, NY.  Sichenzia Ross Ference Kesner LLP (“SRFK”) represented The Acolyte Group, a New York based provider of fully integrated LED lighting systems, in the sale of its entire business to General LED, a portfolio company of Houston, Texas based private equity firm Cap Street Group.

The SRFK team was led by Partners Thomas Rose and Gregory Sichenzia and Counsel Jeff Cahlon with assistance from Counsel Todd Manister from the SRFK Real Estate Group.

Sichenzia Ross Ference Kesner LLP Represents A.G.P/ Alliance Global Partners (through Euro Pacific Capital) in $8 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

cocrystal pharma

Press Release – New York, NY – May 3rd, 2018 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented A.G.P./Alliance Global Partners, offering securities through Euro Pacific Capital, in an underwritten public offering of shares of common stock of Cocrystal Pharma, Inc. (NASDAQ: COCP). Cocrystal sold an aggregate of 4,210,527 shares of common stock at a price of $1.90 per share. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses.  The Sichenzia Ross Ference Kesner LLP team was led by partners Marc Ross, Avital Perlman and Tom Rose.

Sichenzia Ross Ference Kesner LLP Represents Sunworks, Inc., in a $3.75 Million Debt Transaction

sunworks solar power

Press Release – New York, NY – April 27, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented Sunworks, Inc. (NASDAQ: SUNW), a premier provider of high performance solar power systems, in a $3.75 million two year term loan transaction. The lender is CrowdOut Capital LLC. Management, including the Chief Financial Officer, also participated in $750,000 of the loan amount.

The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and Marcelle Balcombe.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corp. in $4 Million Underwritten Public Offering

new age beverage corp. logo

Press Release – New York, NY – April 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented New Age Beverages Corp.  (NASDAQ: NBEV) in a public offering of 2,285,715 shares of its common stock at a price of $1.75 per share for gross proceeds to NBEV of $4,000,000. A.G.P/ Alliance Global Partners  (Euro Pacific Capital) and Maxim Group L.L.C. acted as the Joint Book Running Managers for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, and Counsel Jeff Cahlon.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a Unit of H.C Wainwright, in a  $10.5 Million Public Offering of Medical Transcript Billing, Corp.

mtbc.com logo

Press Release – New York, NY – April 11, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (NASDAQ: MTBC).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents AYTU Bioscience, Inc., in $12 Million Public Offering

aytu bioscience

Press Release – New York, NY – March 6, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented AYTU Bioscience, Inc. (NASDAQ: AYTU) in a $12 million public offering of Class A Units, comprising common stock and warrants and Class B Units comprising Series B Preferred Stock and Warrants. A total of 19,520,000 Class A Units were sold at a price of $0.45 per unit and 3,216 Class B Units were sold at a price of $1,000 per unit.  The warrants are exercisable at a price of $0.54 per share for a term of 5 years. Joseph Gunnar & Co. acted as the Sole Book Running Managing Underwriter and Fordham Financial Management, Inc. acted as the Lead Managing Underwriter.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in a $5 Million Private Placement

moneyonmobile-logo

Press Release – New York, NY – February 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented MoneyOnMobile, Inc. (“MOMT”), a global mobile payments technology and processing company, in a private placement offering with accredited investors in which MOMT received $4,998,000 in consideration for the issuance of 1,666 shares of Series H Preferred Stock and a five year warrant to purchase 3,332,000 shares of common stock at an exercise price of $0.50 per share.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in $7.6 Million of Private Placements

moneyonmobile-logo

Press Release – New York, NY – February 8, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented MoneyOnMobile, Inc. (“MOMT”), a global mobile payments technology and processing company, in a private placement offering with accredited investors where MOMT sold an aggregate of 5,567 shares of Series F Preferred Stock.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Roth Capital Partners and Brookline Securities in a $5.5 Million Public Offering of QBIO Med.

QBioMed

Press Release – New York, NY – February 1, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Roth Capital Partners LLC as lead Placement Agent and CIM/Brookline Securities, as Co-Lead Placement Agent in a public offering of Common Stock and Warrants Series for QBIO Med, Inc. (OTC.QBIO). QBIO is a biotechnology acceleration and development company focused on acquiring and in-licensing life science therapeutics products.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $30 Million Above-Market Registered Direct Offering

vuzix view the future logo

Press Release – New York, NY – January 26, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 3,000,000 million registered shares of its common stock at a price of $10.00 per share and 1,200,000 1 year common stock purchase warrants with an exercise price of $10.00 per share  for gross proceeds to Vuzix of $30,000,000. Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Biotricity Inc. in $2.5 Million Registered Direct Offering

biotricity logo

Press Release – New York, NY – December 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Biotricity Inc. (OTCQB:BTCY”) in a Registered Direct public offering of 450,164 registered shares of its common stock at a price of $5.50 per share for aggregate proceeds of approximately $2.5 million.

The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $12.5 Million Registered Direct Offering

Vuzix Corporation

Press Release – New York, NY – December 18, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2,066,116 million registered shares of its common stock at a price of $6.05 per share and 1,033,058 3-year common stock purchase warrants with an exercise price of $7.00 per share  for gross proceeds to Vuzix of $12,500,000.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a unit of H.C Wainwright, in a $3.9 Million Public Offering of Medical Transcript Billing, Corp.

mtbc - medical transcription billing corp. logo

Press Release – New York, NY – December 11, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.58 Million Registered Direct Offering and Concurrent Private Placement

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – December 6, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering and private placement offering of 7,151,146 shares of common stock and restricted five-year warrants to purchase up to 7,151,146 shares of common stock exercisable at $1.09 per warrant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $12.0 Million Firm Commitment Public Offering

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – November 9, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a firm commitment underwritten offering of 9,009,478 shares of common stock, 4,034 shares of preferred stock (each of which shares is an equivalent of 920 shares of common stock), and five-year warrants to purchase up to 7,478,228 shares of common stock exercisable at $1.05 per warrant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $6.75 Million Registered Direct Offering of Common Stock of Ampio Pharmaceuticals, Inc.

ampio pharmaceuticals

Press Release – New York, NY – October 18, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as Lead Placement Agent and Fordham Financial Management Co-Placement Agent  in a $6.75 million Registered Direct Public Offering of Common Stock of Ampio Pharmaceuticals, Inc. (“NYSE.AMPE”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $1.56 Million Shelf Take Down

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – October 12, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Pareteum Corporation (“Pareteum”), a rapidly growing mobile Cloud Communications Platform company, in connection with its shelf take down of 1,495,000 shares of its common stock. Gross proceeds to Pareteum from this offering are $1,569,750 before deducting placement agent’s commissions and other expenses.  Dawson James Securities acted as placement agent for the offering.

The Sichenzia Ross Ference Kesner LLP team was led by Partner Darrin M. Ocasio, Counselors Jeffrey Cahlon, and Cheryll J. Calaguio and Associate Evan Berger.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $6.0 Million Public Offering of Medical Transcript Billing, Corp.

mtbc.com logo

Press Release – New York, NY – September 28, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

continue reading >>

Sichenzia Ross Ference Kesner LLP Real Estate Group Represents One Wall Partners in a $63 Million, 16-Building, Portfolio Acquisition

one wall partners

Press Release – New York, NY – September 20, 2017 – The real estate practice group of SRFK announced today that it recently closed on a $63 million, 16 building, multi-family, portfolio acquisition for One Wall Partners.  One Wall Partners is a vertically integrated real estate investment firm that specializes in the acquisition, development and management of transit-oriented workforce housing.  The Sichenzia Ross Ference Kesner LLP team was led by partner Anthony Ficara, counsel Michael Wickersham and associate Laura Kim.

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co., LLC in $10 Million Public Offering of American Depository Shares of BiondVax Pharmaceuticals Ltd. (Israel)

biondvax pharmaceuticals

Press Release – New York, NY – September 19, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC. as sole book running manager in the underwritten public offering of American Depository Shares (ADS’s) of BiondVax Pharmaceuticals, Ltd. (NASDAQ: BVXV, TASE BVXV), a clinical stage biopharmaceutical company focused on developing a universal flu vaccine. The public offering consisted of 1,500,000 ADS’s and the full overallotment of 166,667 additional ADS’s at a public offering price of $6.00 per ADS for gross proceeds of $10 million.  The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia and Avital Perlman, Counsel Jeffrey Cahlon and Associate Evan Berger.

Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. in $6 Million Public Offering of Units of Precipio, Inc.

precipio diagnostics

Press Release – New York, NY – August 23rd, 2017 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of Units of Precipio, Inc. (NASDAQ: PRPO). Each Unit is comprised of 1 share of Series B Preferred Stock which is convertible into 400 shares of common stock at a price of $2.50 per share and one warrant to purchase 400 shares of common stock at $3.00 per share.   Precipio provides diagnostic information to physicians and there patients worldwide.  The Sichenzia Ross Ference Kesner LLP team was led by partner Tom Rose and counsel Jeff Cahlon.

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $11.8 PIPE financing of Aytu Bioscience, Inc.

aytu bioscience

Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as lead placement agent and Fordham Financial Management, Inc. co-placement agent  in a private placement offering of equity securities of Aytu BioScience, Inc.  (OTC Market “AYTU”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $8.6 Million Registered Direct Offering

vuzix view the future logo

Press Release – New York, NY – August 14, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 1.5 million registered shares of its common stock at a price of $5.75 per share  for gross proceeds to Vuzix of $8,625,000.Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Kesner LLP Represents JetSmarter Inc. in Institutional Investment from Clearlake Capital Group and Leucadia National Corporation

jetsmarter_logo

Press Release — August 10, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP represented JetSmarter Inc., an innovative technology company and market leader in the premium private-flight-sharing economy, in an institutional capital raise.  The investment was anchored by lead sponsor, Clearlake Capital Group, L.P. and included participation from Leucadia National Corporation and existing investors.  Jefferies LLC acted as the exclusive placement agent to JetSmarter Inc. in connection with the financing.

continue reading >>